High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients
- PMID: 32675560
- DOI: 10.1097/QAD.0000000000002574
High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients
Abstract
Objective: HIV-1-associated dysbiosis is most commonly characterized by overall decreased diversity, with abundance of the genus Prevotella, recently related to inflammatory responses.
Design: A pilot study including 10 antiretroviral therapy-treated HIV-1-infected men and 50 uninfected controls was performed to identify the main gut dysbiosis determinants (e.g. Prevotella enrichment), that may affect mucosal antiviral defenses and T cell immunity in HIV-1-infected individuals.
Methods: 16rRNA gene sequencing was applied to the HIV-1-infected individuals' fecal microbiota and compared with controls. Measurements of CD4 and CD8 T cell activation [CD38, human leukocyte antigen (HLA)-DR, CD38 HLA-DR] and frequencies of Th17, obtained from lamina propria lymphocytes isolated from five different intestinal sites, were performed by flow cytometry. IFNβ, IFNAR1 and MxA gene expression level was evaluated by real-time PCR in lamina propria lymphocytes. Nonparametric t tests were used for statistical analysis.
Results: HIV-1-infected men had a significant fecal microbial communities' imbalance, including different levels of genera Faecalibacterium, Prevotella, Alistipes and Bacteroides, compared with controls. Notably, Prevotella abundance positively correlated with frequencies of CD4 T cells expressing CD38 or HLA-DR and coexpressing CD38 and HLA-DR (P < 0.05 for all these measures). The same trend was observed for the activated CD8 T cells. Moreover, Prevotella levels were inversely correlated with IFN-I genes (P < 0.05 for IFNβ, IFNAR1 and MxA genes) and the frequencies of Th17 cells (P < 0.05). By contrast, no statistically significant correlations were observed for the remaining bacterial genera.
Conclusion: Our findings suggest that Prevotella enrichment might affect gut mucosal IFN-I pathways and T cell response in HIV-1-infected patients, thus contributing to immune dysfunction.
Similar articles
-
Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.J Med Virol. 2016 Aug;88(8):1347-56. doi: 10.1002/jmv.24475. Epub 2016 Jan 20. J Med Virol. 2016. PMID: 26765625
-
[Study on the correlation between viral load and activation and exhaustion levels of CD8+T cells in HIV/AIDS patients].Zhonghua Yu Fang Yi Xue Za Zhi. 2024 Nov 6;58(11):1690-1696. doi: 10.3760/cma.j.cn112150-20231219-00462. Zhonghua Yu Fang Yi Xue Za Zhi. 2024. PMID: 39537407 Chinese.
-
During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.Clin Immunol Immunopathol. 1995 Oct;77(1):33-41. doi: 10.1016/0090-1229(95)90134-5. Clin Immunol Immunopathol. 1995. PMID: 7554481
-
HIV enteropathy and 'Slim disease': Historical and current perspectives.Int J Infect Dis. 2024 Feb;139:86-91. doi: 10.1016/j.ijid.2023.11.037. Epub 2023 Dec 4. Int J Infect Dis. 2024. PMID: 38052315 Review.
-
"Go", "No Go," or "Where to Go"; does microbiota dictate T cell exhaustion, programming, and HIV persistence?Curr Opin HIV AIDS. 2021 Jul 1;16(4):215-222. doi: 10.1097/COH.0000000000000692. Curr Opin HIV AIDS. 2021. PMID: 34039845 Free PMC article. Review.
Cited by
-
Immune activation and inflammation in lactating women on combination antiretroviral therapy: role of gut dysfunction and gut microbiota imbalance.Front Immunol. 2023 Nov 16;14:1280262. doi: 10.3389/fimmu.2023.1280262. eCollection 2023. Front Immunol. 2023. PMID: 38045684 Free PMC article.
-
Growth faltering regardless of chronic diarrhea is associated with mucosal immune dysfunction and microbial dysbiosis in the gut lumen.Mucosal Immunol. 2021 Sep;14(5):1113-1126. doi: 10.1038/s41385-021-00418-2. Epub 2021 Jun 22. Mucosal Immunol. 2021. PMID: 34158595 Free PMC article.
-
Gut Innate Immunity and HIV Pathogenesis.Curr HIV/AIDS Rep. 2021 Apr;18(2):128-138. doi: 10.1007/s11904-021-00544-3. Epub 2021 Mar 9. Curr HIV/AIDS Rep. 2021. PMID: 33687703 Free PMC article. Review.
-
The Gut Microbiome: Another Piece in the Puzzle of HIV-Associated Atherosclerosis.J Infect Dis. 2025 Jul 11;231(6):1347-1348. doi: 10.1093/infdis/jiae244. J Infect Dis. 2025. PMID: 38742649 Free PMC article. No abstract available.
-
Alterations in the gut microbiota of AIDS patients with pneumocystis pneumonia and correlations with the lung microbiota.Front Cell Infect Microbiol. 2022 Oct 21;12:1033427. doi: 10.3389/fcimb.2022.1033427. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36339339 Free PMC article.
References
-
- Dillon SM, Frank DN, Wilson CC. The gut microbiome and HIV-1 pathogenesis: a two-way street. AIDS 2016; 30:2737–2751.
-
- Nowak P, Troseid M, Avershina E, Barqasho B, Neogi U, Holm K, et al. Gut microbiota diversity predicts immune status in HIV-1 infection. AIDS 2015; 29:2409–2418.
-
- Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ, et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med 2013; 5:193ra191.
-
- Mutlu EA, Keshavarzian A, Losurdo J, Swanson G, Siewe B, Forsyth C, et al. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog 2014; 10:e1003829.
-
- Lozupone CA, Li M, Campbell TB, Flores SC, Linderman D, Gebert MJ, et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe 2013; 14:329–339.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials